<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Kalbe Farma Tbk Pt — News on 6ix</title>
    <link>https://6ix.com/company/kalbe-farma-tbk-pt</link>
    <description>Latest news and press releases for Kalbe Farma Tbk Pt on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 11 Dec 2025 12:59:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/kalbe-farma-tbk-pt" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683637e278dffbe2df14b37a.webp</url>
      <title>Kalbe Farma Tbk Pt</title>
      <link>https://6ix.com/company/kalbe-farma-tbk-pt</link>
    </image>
    <item>
      <title>Kalbe Farma and LIFE AI Unveil StrokeGENME to Personalize Stroke Prevention at National Scale</title>
      <link>https://6ix.com/company/kalbe-farma-tbk-pt/news/kalbe-farma-life-ai-unveil-125900146</link>
      <guid isPermaLink="true">https://6ix.com/company/kalbe-farma-tbk-pt/news/kalbe-farma-life-ai-unveil-125900146</guid>
      <pubDate>Thu, 11 Dec 2025 12:59:00 GMT</pubDate>
      <description>SINGAPORE, Dec. 11, 2025 (GLOBE NEWSWIRE) -- In a pioneering advancement that aims to reduce the increasing problem of strokes, PT Kalbe Farma Tbk - the largest publicly listed pharmaceutical company in Southeast Asia - through its subsidiary Kalgen Innolab Clinical Laboratory (Innolab) has announced StrokeGENME, a genetics-powered platform that translates DNA insights into individualized stroke-prevention plans, delivered through Kalbe’s nationwide ecosystem. Indonesia’s leading healthcare ente</description>
    </item>
  </channel>
</rss>